Seeking to ensure the quality and safety of pharmaceutical products, India's regulatory bodies have intensified their ...

US pharma major Pfizer (NYSE: PFE) reported new Phase III data over the weekend showing that its investigational PD-1 ...

Among research news last week, Gilead Sciences released positive new Phase III data on progression fee survival for its Trodelvy plus Keytruda in breast cancer. Roivant company Immunovant last week ...

US biotech giant Amgen (Nasdaq: AMGN) is the latest to build up its US base, as on Friday the company announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Beyonttra (acoramidis), from Germany’s Bayer ...

The European Medicines Agency’s (EMA)) human medicines committee (CHMP) has recommended seven novel medicines for approval at ...

US drugmaker AbbVie was trading nearly 3% higher lunchtime Friday following the presentation of its first-quarter financial ...

Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...

Chinese biotech LTZ Therapeutics has closed an oversubscribed series A+ financing round, raising $40 million to support its ...

A new analysis by Charles River Associates, commissioned by European industry group EFPIA, suggests that a proposed reward ...

California-based biotech Halozyme Therapeutics (Nasdaq: HALO) yesterday revealed it has filed a patent infringement lawsuit ...

UK-listed medtech Convatec Group (LSE: CTEC) plans to launch its new wound care technology, ConvaNiox (nitric oxide), later ...